Some 575,000 animals were used in scientific experiments in Switzerland last year, up 3% from 2020 and the first increase in five years, reports the Federal Food Safety and Veterinary Office (FSVO).
Testing involving the highest level of pain for the animals (grade 3) rose by 31%, while grade 2 testing rose 10% and grade 1 by 13%, according to a FSVO press releaseExternal link on Tuesday. Mice were the animals most frequently used.
Approximately 93% of the grade 3 experiments were carried out as part of research on human diseases such as cancer and neurological diseases like dementia and multiple sclerosis. A sharp increase in grade 3 experiments has been observed since 2014, said the FSVO.
In 2021, the federal government launched a research programme to reduce the number of animal experiments in research and to reflect on ethical and societal issues, but animal testing remains at a high level, notes the office. “Experience shows that it may take several years before such measures begin to bear fruit,” said the FSVO.
It assumes that some experiments planned for 2020 were postponed due to the Covid-19 pandemic and were only carried out in 2021, which may help explain the increase.
The Swiss League against Animal Testing and for Animal Rights (LSCV) called the latest statistics “a scandal”. It noted the pain of the animals, for example due to tumours which are introduced into their bodies.
The committee that launched a popular initiative to ban animal testing and the import of medicines tested on animals, which Swiss voters rejected in February, said it wanted to launch a new initiative that would not include the import ban. In 40 years, the Swiss people have already voted five times on the issue of animal testing.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
Animal testing drops in Switzerland despite Covid research
This content was published on
Approximately 556,000 animals were used for experimental purposes in Switzerland last year, according to statistics compiled by the Federal Office for Food Safety and Veterinary Affairs (FVOV). That figure represents a drop of 2.8% compared to 2019 and a decrease of 18% relative to 2015, when the downward trend started. Restrictions imposed by the government to deal with…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.